[go: up one dir, main page]

ATE397943T1 - Massnahmen welche die effekte einer kalorischen beschränkung nachahmen - Google Patents

Massnahmen welche die effekte einer kalorischen beschränkung nachahmen

Info

Publication number
ATE397943T1
ATE397943T1 AT00988400T AT00988400T ATE397943T1 AT E397943 T1 ATE397943 T1 AT E397943T1 AT 00988400 T AT00988400 T AT 00988400T AT 00988400 T AT00988400 T AT 00988400T AT E397943 T1 ATE397943 T1 AT E397943T1
Authority
AT
Austria
Prior art keywords
calorie
interventions
mimic
effects
restriction
Prior art date
Application number
AT00988400T
Other languages
English (en)
Inventor
Stephen Spindler
Joseph Dhahbi
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE397943T1 publication Critical patent/ATE397943T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00988400T 1999-12-23 2000-12-22 Massnahmen welche die effekte einer kalorischen beschränkung nachahmen ATE397943T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47122499A 1999-12-23 1999-12-23
US09/648,642 US6406853B1 (en) 1999-12-23 2000-08-25 Interventions to mimic the effects of calorie restriction

Publications (1)

Publication Number Publication Date
ATE397943T1 true ATE397943T1 (de) 2008-07-15

Family

ID=23870767

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00988400T ATE397943T1 (de) 1999-12-23 2000-12-22 Massnahmen welche die effekte einer kalorischen beschränkung nachahmen

Country Status (2)

Country Link
US (1) US6406853B1 (de)
AT (1) ATE397943T1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
WO2001012851A2 (en) * 1999-08-12 2001-02-22 Wisconsin Alumni Research Foundation Identification of genetic markers of biological age and metabolism
CA2441086A1 (en) * 2001-03-19 2002-09-26 Wisconsin Alumni Research Foundation Identification of gene expression alterations underlying the aging process in mammals
WO2003000861A2 (en) 2001-06-22 2003-01-03 The Regents Of The University Of California Eukaryotic genes involved in adult lifespan regulation
AU2002345839A1 (en) * 2001-06-26 2003-03-03 Wisconsin Alumni Research Foundation Gene expression alterations underlying the retardation of aging by caloric restriction in mammals
EP1451345A4 (de) * 2001-08-15 2006-03-01 Elixir Pharmaceuticals Inc Mit alter assoziierte marker
US7666459B2 (en) * 2001-09-12 2010-02-23 The Procter & Gamble Company Pet food compositions
US20050013776A1 (en) * 2003-07-16 2005-01-20 Spindler Stephen R. Methods of evaluating the dynamics of caloric restriction and identifying caloric restriction mimetics
US20040191775A1 (en) * 2003-03-12 2004-09-30 Spindler Stephen R. Methods of analyzing genes affected by caloric restriction or caloric restriction mimetics
US20050054599A1 (en) * 2003-05-02 2005-03-10 Coles John G. Biosynthetic platform for cardioprotective stress response in human fetal heart tissue
US20040220125A1 (en) * 2003-05-02 2004-11-04 Coles John G. Biosynthetic platform for cardioprotective gene expression using immature heart tissue
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20090252834A1 (en) * 2004-05-10 2009-10-08 Michael Griffin Hayek Compositions comprising glucose anti-metabolites
US20070118295A1 (en) * 2005-03-02 2007-05-24 Al-Murrani Samer Waleed Khedhe Methods and Systems for Designing Animal Food Compositions
WO2006130188A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic bifidobacteria
DK1880001T3 (da) 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
AU2007211625B2 (en) * 2006-02-01 2012-08-23 Nestec S.A. Nutritional system and methods for increasing longevity
US8403844B2 (en) * 2006-03-16 2013-03-26 Biomarker Pharmaceuticals, Inc. Methods for interventions
US7960605B2 (en) 2006-03-17 2011-06-14 BioMaker Pharmaceuticals, Inc. Methods for testing for caloric restriction (CR) mimetics
CN101711158A (zh) 2007-02-01 2010-05-19 爱默思公司 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法
US8420088B2 (en) 2008-01-28 2013-04-16 Novartis Ag Methods and compositions using FGF23 fusion polypeptides
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CN102695807B (zh) 2009-11-10 2016-02-24 雀巢产品技术援助有限公司 心脏衰老生物标志物及其用途
WO2011060305A1 (en) * 2009-11-12 2011-05-19 Nox Technologies, Inc. Potato skin compositions that lower cytosolic nadh level to mimic calorie restriction
WO2013027191A1 (en) 2011-08-25 2013-02-28 Novartis Ag Methods and compositions using fgf23 fusion polypeptides
EP3510875B1 (de) * 2013-02-12 2020-06-10 University of Southern California Diätzusammensetzung zur therapeutischen verwendung zur senkung des blutzuckerspiegels - und oder des igf-1-spiegels
KR20170084332A (ko) 2014-12-04 2017-07-19 노파르티스 아게 Klotho 변이체 폴리펩티드를 사용하는 방법 및 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001012851A2 (en) 1999-08-12 2001-02-22 Wisconsin Alumni Research Foundation Identification of genetic markers of biological age and metabolism

Also Published As

Publication number Publication date
US6406853B1 (en) 2002-06-18

Similar Documents

Publication Publication Date Title
ATE397943T1 (de) Massnahmen welche die effekte einer kalorischen beschränkung nachahmen
DE69637816D1 (de) Der expression von genen, welche spezifisch sind für die stärkebiosynthese
WO2000018918A3 (en) Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
AU2003277508A1 (en) Learning/thinking machine and learning/thinking method based on structured knowledge, computer system, and information generation method
WO2004006747A3 (en) System and method for training of cognitive skill
ATE261331T1 (de) Verfahren und tragbares trainingsgerät zum optimieren eines trainings
ATE339196T1 (de) Zelladhäsionsinhibitoren
DE60040369D1 (de) Druckvorrichtung, Steuerverfahren für die Vorrichtung, und Computer lesbarer Aufzeichnungsträger
AU6720996A (en) Methods for drug screening
WO2004112168A3 (en) Part tester and method
BR0209851B8 (pt) Métodos para a instalação de uma viga em i e uma viga em cruz alongadas, e, conexão de uma viga em cruz.
NO20034484L (no) Anordning for styring og/eller utproving av et undervanns hydrokarbonproduksjonssystem.
WO2004017181A3 (en) Computer-aided education systems and methods
DE602004017491D1 (de) Präbiotische effektanalyse
DE69711781D1 (de) Vorrichtung zum Erzeugen von Eingangsdaten für einen Interpolator
WO2003078574A3 (en) Novel metabolic targets and markers
FI20002205L (fi) Menetelmä kauratuotteen valmistamiseksi ja menetelmällä valmistettu kauramuro ja välipalatuote
NO20053344D0 (no) Fremgangsmate for a generere en genetisk modifisert organisme for a screene aktive substanser.
WO2005016287A3 (en) Prkwnks as modifiers of the rac pathway and methods of use
ATE235711T1 (de) Operandenstapelspeicher und verfahren zum betreiben eines operandenstapelspeichers
WO2003036261A3 (en) Drug development by rapid neuroimaging of neural cells
SE0301049D0 (sv) Control System, computer program product, device and method
WO2003087336A3 (en) Estrogen receptor alpha regulated gene expression, related assays and therapeutics
WO2003035898A1 (fr) Methode de criblage d'un medicament agissant sur la paroi cellulaire
WO2005016282A3 (en) Prkcs as modifiers of the beta catenin pathway and methods of use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties